CASE DISCUSSION
Coronary Artery Disease: From Medical Therapy to Intervention
Presented by Dr Argyrios S. NtalianisViews
313,692
Credit Points
Learning Hours
CPD Points
CME Points
Courses Completed
Case Description
Coronary artery disease (CAD) remains a leading cause of morbidity and mortality worldwide. Management begins with optimal medical therapy, including antiplatelets, statins, beta-blockers, ACE inhibitors, and lifestyle modification to reduce risk factors. For patients with persistent symptoms or...
Case Summary
- Coronary artery disease (CAD) prevalence varies globally, with higher rates in North Africa, the Middle East, and Russia, while North America, Western Europe, and Australia have lower rates. In the US, nearly 20 million people have CAD, and its prevalence is influenced by age and gender. Despite a decline in CAD-related deaths, it remains a leading cause of mortality.
Speaker Profile
Dr Argyrios S. Ntalianis
Consultant in Cardiology & Interventional Cardiology Head of the CAD and Cardiomyopathy Unit Alexandra Hospital, Athens, GreeceDisclosures
Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.